Does UnitedHealthcare cover Wegovy в 2026?
Wegovy (generic: semaglutide) is FDA-approved для chronic weight management. Coverage hinges on whether your employer plan includes an obesity-treatment benefit — many commercial plans exclude it.
Last verified 2026-06-01. Coverage changes — always confirm with your plan administrator.
1. UnitedHealthcare coverage status for Wegovy
Depends on your specific plan. Coverage swings widely between employer plans. PPO + HMO tiers, group vs individual, и state regulation all factor.
2. Prior-authorization criteria
UnitedHealthcare typically requires the prescriber к document:
- BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (hypertension, dyslipidemia, type 2 diabetes, sleep apnea)
- Documented weight-management attempts (diet + exercise) over 6+ months
- Plan benefit must include obesity-treatment coverage (most commercial plans exclude this benefit)
- Provider attestation + supervised treatment plan
3. Step-therapy requirements
Before approving Wegovy, UnitedHealthcare typically requires trial + documented failure of:
- Lifestyle program documentation
- Older anti-obesity meds (phentermine, Saxenda) — varies by plan
4. Common reasons for denial
- Plan benefit excludes obesity treatment
- BMI below threshold
- Insufficient documented lifestyle attempts
- Comorbidity not adequately documented
5. If denied — how к appeal
If denied, request the written denial letter (legally required), then file а written appeal within the timeline stated. Include: physician letter of medical necessity, lab values, treatment history, and any peer-reviewed clinical evidence. If first appeal fails, escalate к external review through your state insurance commissioner.
Tip: request your physician's office submit а formal "letter of medical necessity" — these significantly improve appeal outcomes.
6. If uncovered — affordable alternatives
If UnitedHealthcare denies coverage и appeal fails, cash-pay options exist:
- Manufacturer savings programs — Novo Nordisk NovoCare savings cards (verify eligibility on the manufacturer site)
- Compounded semaglutide via licensed compounding pharmacies — typically $200-400/mo cash-pay
- See our Wegovy provider list для current pricing across telehealth programs